Evidence map›Paper›PMID 34184188›Full record

ArticleEndocrine2021

"Thyroid nodular disease and PTEN mutation in a multicentre series of children with PTEN hamartoma tumor syndrome (PHTS)".

Gerdi Tuli, Jessica Munarin, Alessandro Mussa, Diana Carli, Roberto Gastaldi, Paola Borgia, Maria Cristina Vigone, Marco Abbate, Giovanni Battista Ferrero, Luisa De Sanctis

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Endocrine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. The cross-talk between GSK-3β, RKIP, and PTEN as potential targets for therapeutic implications in cancer: a comprehensive insight.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Characteristics ofCancers · 2023
    Article
  9. Editorial: Thyroid nodules and tumors in childhood.Frontiers in endocrinology · 2023
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Gerdi TuliDepartment of Pediatric Endocrinology, Regina Margherita Children Hospital, Turin, Italy. gerdi.tuli@unito.it.ORCID http://orcid.org/0000-0001-5862-8958
Jessica MunarinDepartment of Pediatric Endocrinology, Regina Margherita Children Hospital, Turin, Italy.
Alessandro MussaDepartment of Public Health and Pediatrics, University of Turin, Turin, Italy.
Diana CarliDepartment of Public Health and Pediatrics, University of Turin, Turin, Italy.
Roberto GastaldiDepartment of Paediatrics Gaslini Hospital, Genova, Italy.
Paola BorgiaDepartment of Paediatrics Gaslini Hospital, Genova, Italy.
Maria Cristina VigoneDepartment of Pediatrics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Marco AbbateDepartment of Pediatrics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Giovanni Battista FerreroDepartment of Public Health and Pediatrics, University of Turin, Turin, Italy.
Luisa De SanctisDepartment of Pediatric Endocrinology, Regina Margherita Children Hospital, Turin, Italy.
Ospedale Regina Margherita · ITUniversity of Turin · ITIstituto Giannina Gaslini · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report the incidence of 4-12% of differentiated thyroid cancer (DTC) and up to 50% of benign thyroid nodular disease and to describe nodular thyroid disease in a multicentre pediatric population with PTEN mutations.

methodsRetrospective data of pediatric patients with PTEN mutations collected from tertiary Departments of Pediatric Endocrinology of Turin, Milan and Genua, Italy, in the period 2010-2020.

resultsSeventeen children with PTEN mutations were recruited in the study. Thyroid involvement was present in 12/17 (70.6%) subjects, showing a multinodular struma in 6/17 (35.3%), nodules with benign ultrasound features in 5/17 (29.4%) and a follicular adenoma in 1/17 (6%). No correlation was found between thyroid disease and gender, puberty, vascular manifestations, delayed development, or brain MRI abnormalities, while multiple lipomas were associated with thyroid disease (p = 0.03), as was macrocephaly. Standard Deviation (SD) score head circumference was 4.35 ± 1.35 cm in subjects with thyroid disease, 3 ± 0.43 cm (p = 0.02) in the group without thyroid disease. Thyroid involvement was present in all subjects with mutations in exon 6 (4/4) and exon 8 (3/3) of the PTEN gene (p = 0.02).

conclusionIn the presented cohort, benign thyroid disorders were prevalent, with no evidence of DTC. A correlation was found between thyroid lesions and head circumference and the occurrence of multiple lipomas. Future studies in larger cohorts should assess whether risk stratification is needed when recommending surveillance strategies in children or young adolescents with PTEN hamartoma syndrome.

Indexed as

Hamartoma Syndrome, MultipleThyroid DiseasesAdolescentChildHumansMutationPTEN PhosphohydrolaseRetrospective StudiesPTEN PhosphohydrolasePTEN protein, humanDifferentiated thyroid cancerPediatric agePTEN mutationThyroid nodule

Identifiers

PMID34184188
PMCPMC8571202
OpenAlexW3176242583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.